A review of the comprehensiveness of provincial drug coverage for Canadian seniors

Canadian Journal on Aging

Volumn 22, Issue 1, 2003, Pages 33-44

  Grootendorst, Paul ^a,b,c   Palfrey, Dan ^d   Willison, Donald ^b,c   Hurley, Jeremiah ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^d MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Aging; Cost sharing; Drug costs; Drug subsidies; Prescription drug insurance; Prescription drugs; Provincial drug plans; Seniors

Indexed keywords

DRUG;

AGED; AGING; CANADA; COMPARATIVE STUDY; COST; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG FORMULARY; DRUG USE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOME; HOSPITAL PATIENT; HUMAN; INCOME; OUTPATIENT; PHARMACEUTICAL CARE; PRESCRIPTION; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; SIMULATION; STATISTICAL ANALYSIS;

EID: 0037599604     PISSN: 07149808     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0714980800003718     Document Type: Review

References (19)

1. Grootendorst P, Levine M. Do drug plans matter? Effects of drug plan eligibility on drug use among the elderly, social assistance recipients and the general population. Final report to the Health Transitions Fund, pursuant to grant NA227; 2000.
2. National Forum on Health. Canada health action: building on the legacy. Final report of the National Forum on Health. Ottawa: Minister of Public Works and Government Services; 1997.
3. Soumerai SB, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees - a call to action. N Engl J Med 1999;340(9):722-728 [published erratum appears in N Engl J Med 1999;340(12):976].
4. Tamblyn R, Perreault R. Prescription drug use and seniors. Can J Aging 2000;19(1):143-175.
5. Tamblyn R, McLeod P, Abrahamowicz M, Monette J, Gayton D, Berkson L, Jones R. Questionable prescribing for elderly patients in Quebec. CMAJ 1994;150(11):1801-1809.
6. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-121.
7. Lichtenberg FR. Pharmaceutical innovation, mortality reduction and economic growth. In: Murphy K, Topel R, editors. The value of medical research. Chicago, IL: University of Chicago Press, 2000.
8. Canadian Institute for Health Information. National health expenditure trends 1975-2000. Ottawa, ON: Canadian Institute for Health Information; 2000.
9. Applied Management, Inc. Canadians' access to insurance for prescription medicines. Toronto, ON: Applied Management, Inc.; 2000.
10. Grootendorst P. Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment. Can J Clin Pharmacol 2002;9:79-99.
11. Gregoire J-P, MacNeil P, Skilton K, Moisan J, Menon D, Jacobs P et al. Inter-provincial variation in government drug formularies. C J Public Health 2001;92(4):307-312.
12. Canadian Pharmacists Association. Provincial drug benefit programs, editions 17-22 (1997-1999). Ottawa, ON: Canadian Pharmacists Association; 1999.
13. Intercontinental Medical Statistics, Inc. 1999 Canadian pharmaceutical industry review. Mississauga, ON: IMS Health March; 2000.
14. Human Resources Development Canada. The ISP stats book - statistics related to income security programs: summer 2000. [Online]. 2001 [cited 2003 Feb 5]. Available from: URL:http://www.hrdc-drhc.gc.ca/isp/ studies/trends/statbook/ispstatbook.pdf.
15. Price Waterhouse Coopers. Health insider survey no. 2. Toronto, ON: Price Waterhouse Coopers; 1999.
16. Lindsey R, West DS. National pharmacare, reference based pricing, and drug R&D: a critique of the National Forum on Health's recommendations for pharmaceutical policy. Can Public Policy 1999;25:1-27.
17. National Forum on Health. Directions for a pharmaceutical policy in Canada. In: Canada health action: building on the legacy. Final report of the National Forum on Health. Ottawa: Minister of Public Works and Government Services; 1997. p. 17.
18. Alan S, Crossley TF, Grootendorst P, Veall MR. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada. J Health Econ 2002;21(5):87-108.
19. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-429.